Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2005
12/14/2005CN1231589C Eukaryotic gene expression cassette and uses thereof
12/14/2005CN1231588C Morphological mutants of filamentous fungi
12/14/2005CN1231587C Beet black withered virus as expression carrier of foreigh gene
12/14/2005CN1231586C Polymorphic saccharomyces hansenii expression recombination cholere toxin B subunit gene and its application
12/14/2005CN1231585C Method for preparing recombinant duck interleukin-2 protein and its application
12/14/2005CN1231584C Cell proliferation factor Fwap 10576
12/14/2005CN1231583C Method for generating split, non-transferable genes that are able to express an active protein product
12/14/2005CN1231582C Method for controlling plant flower bud areloe position and use thereof
12/14/2005CN1231581C Pectin degrading enzyme from i(Bacillus licheniformis)
12/14/2005CN1231579C Process for producing trichodiene synzyme
12/14/2005CN1231578C Attenuated virus of ox's viral diarrhea
12/14/2005CN1231574C Corynebaclerium for producing L-lysine and method for producing L-lysine
12/14/2005CN1231497C Novel human protein with function for promoting mouse NIH/313 cell transformation and coding sequence thereof
12/14/2005CN1231496C Human protein with cancer cell growth suppressing function and its coding sequence
12/14/2005CN1231491C Mammal telomerase
12/14/2005CN1231262C Mimetic peptides for epitope of apolipoprotein B-100, concatemer and modified peptides, and vaccine composition comprising the same
12/14/2005CN1231257C Use of preparing medicine for raising genitality of female animals with long PENTRAXIN PTX 3
12/13/2005US6975943 Clone-array pooled shotgun strategy for nucleic acid sequencing
12/13/2005US6974898 Genetically engineering cotton plants which generate amplified endogenous oils; obtain plant, transform, monitor endogenous oil concentration
12/13/2005US6974896 Trace element phytoremediation
12/13/2005US6974895 Transgenic legume plants modified to produce resveratrol glucoside and uses thereof
12/13/2005US6974894 Genetic engineered potato starch; plant extract; adjust physical properties
12/13/2005US6974893 Nucleotide sequences coding polypeptide for use in altering the composition of plant oils, waxes and hydroxylated fatty acids in plants
12/13/2005US6974867 Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers
12/13/2005US6974864 Viral mucleotide sequences for use in the diagnosis and treatment of viral diseases
12/13/2005US6974863 Nucleotide sequences coding receptor protein for use in the treatment of immnological and autoimmune diseases
12/13/2005US6974861 Conjestive heart failure; polypeptide
12/13/2005US6974698 Methods for delivering biologically active molecules into cells
12/13/2005US6974695 Complementing cell lines
12/13/2005US6974694 Adenoviruses for control of gene expression
12/13/2005US6974690 Animal feeds
12/13/2005US6974689 Nucleic acid encoding PRO211 polypeptides
12/13/2005US6974688 Nucleotide sequences coding preferential plypeptide for use in the diagnosis and treatment of hypertension, hypotension, heart disease, asthma, and the like.
12/13/2005US6974687 β1,3-galactosyltransferase and DNA encoding the enzyme
12/13/2005US6974684 Introducing a sample containing specific polypeptide to an antibody that binds immunospecifically to the polypeptide and determining the presence or amount of antibody bound to such polypeptide
12/13/2005US6974683 Polypeptide for use in the diagnosis and treatment of cancer
12/13/2005US6974682 Soluble interleukin-1 receptor accessory molecule
12/13/2005US6974681 Cell culture performance with vanadate
12/13/2005US6974677 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative disorders
12/13/2005US6974670 Method of synthesizing nucleic acid
12/13/2005US6974668 antitumor agent binds to base DNA or RNA sequence; measure cytolysis of tumor cells; drug screening
12/13/2005US6974666 bioassay preparing libraries of diverse DNA sequences and probes for use in screening studies; molecular hybridization, splicing with nucleases and removing non-complementary sections; quantitative fluorescence analysis
12/13/2005US6974581 Multi-component vaccine comprising at least two antigens from haemophilus influenzae to protect against disease
12/13/2005US6974580 Mycobacterial sulfation pathway proteins and methods of use thereof
12/13/2005US6974574 Tat/rev/vpr/nef genes/proteins for vaccines
12/13/2005US6974572 Peptide for use in the treatment of allergic disorders
12/13/2005US6974247 Device for mixing and/or injecting cements
12/13/2005CA2403947C Bir domains of mammalian iap gene family
12/13/2005CA2234073C Coiled-coil heterodimer methods and compositions for the detection and purification of expressed proteins
12/13/2005CA2214837C Method of purification of recombinant viral vectors containing a therapeutic gene
12/13/2005CA2001328C Borrelia antigen
12/10/2005CA2507847A1 Prostaglandin reductase
12/10/2005CA2507738A1 Modulation of peroxisome proliferator-activated receptors
12/08/2005WO2005116645A2 Isolation of allergen-specific immunoglobulin genes from human b-cells from atopy sufferers
12/08/2005WO2005116624A1 Highly sensitive method of detecting single nucleotide polymorphism with the use of photocurrent
12/08/2005WO2005116271A2 Selection of microorganisms with growth dependent upon extracytoplasmic enzymes
12/08/2005WO2005116256A2 Device for extracting biological molecules from tissue specimens
12/08/2005WO2005116255A2 Aptamer-toxin molecules and method for using same
12/08/2005WO2005116254A1 Method of quantitatively evaluating dna methylation
12/08/2005WO2005116253A1 Probe for diagnosis of marfan’s syndrome and method of screening with the probe
12/08/2005WO2005116250A2 Viral and viral associated mirnas and uses thereof
12/08/2005WO2005116245A2 Cdna production from cells after laser microdissection
12/08/2005WO2005116237A2 Site specific incorporation of heavy atom-containing unnatural amino acids into proteins for crystal structure determination
12/08/2005WO2005116236A2 Methods for treating cancer using anti-wnt2 monoclonal antibodies and sirna
12/08/2005WO2005116231A1 Methods for dynamic vector assembly of dna cloning vector plasmids
12/08/2005WO2005116228A2 Fermentative production of fine chemicals
12/08/2005WO2005116226A2 Nanoparticles comprising rna ligands
12/08/2005WO2005116225A1 Method for introducing and expressing rna in cells
12/08/2005WO2005116224A2 Tetracycline-regulated adeno-associated viral (aav) vectors for gene delivery to the nervous system
12/08/2005WO2005116223A1 Method for the production of suitable dna constructs for specific inhibition of gene expression by rna interference
12/08/2005WO2005116222A2 Gene-cassette for enhancement of protein production
12/08/2005WO2005116221A1 Hctla4-ig fusion protein-coding gene, recombinant vector comprising the same, and process for producing hctla4-ig fusion protein using the same
12/08/2005WO2005116219A1 Fluorescent protein
12/08/2005WO2005116218A1 Fusion gene of hepatitis b surface antigen with carboxyl end having pres2 immune determinant and the protein thereof
12/08/2005WO2005116217A1 Glucose isomerase mutants
12/08/2005WO2005116216A1 Oral vaccine against protozoiasis using genetically modified plant
12/08/2005WO2005116215A1 Improvement to the resistance of a plant to destructive insects
12/08/2005WO2005116214A2 Destructive insect-inducible promoters and uses thereof
12/08/2005WO2005116213A2 Directed evolution of proteins
12/08/2005WO2005116212A2 Treatment of neurodegenerative disease through intracranial delivery of sirna
12/08/2005WO2005116211A1 9-fatty acid hydroperoxide lyase genes
12/08/2005WO2005116210A2 Stat6 inhibiting sirna and shrna for use in the treatment of allergic diseases, pathological changes of the respiratory system and cancer
12/08/2005WO2005116209A1 Method and device for the isolation of nucleic acid from nucleic acid comprising material
12/08/2005WO2005116208A1 Dna amplification method
12/08/2005WO2005116207A1 Telomerase-inhibitory ena oligonucleotide
12/08/2005WO2005116206A1 Improved nitrile hydratase
12/08/2005WO2005116205A1 Marker genes for judging paclitaxel-sensitivity and judgment method
12/08/2005WO2005116204A1 Polynucleotide causing rna interfere and method of regulating gene expression with the use of the same
12/08/2005WO2005116203A2 Method and apparatus for bacterial transformation by electroporation with waveforms incorporating pulsed rf between 3 and 125 mhz
12/08/2005WO2005116202A1 Reaction vessel, reaction measuring device, and liquid rotating treatment device
12/08/2005WO2005116200A2 Nucleic acids and polypeptides involved in the production of cryptophycin
12/08/2005WO2005116199A2 Tobacco nicotine demethylase genomic clone and uses thereof
12/08/2005WO2005116184A1 Biosample manipulation apparatus
12/08/2005WO2005116081A2 Stable protein storage and stable nucleic acid storage in recoverable form
12/08/2005WO2005116080A1 Antibody specific for alkylphenol and use thereof
12/08/2005WO2005116079A1 Antibody capable of recognizing ligand of allylhydrocarbon receptor and use thereof
12/08/2005WO2005116074A2 Nucleoproteins displaying native t cell receptor libraries
12/08/2005WO2005116070A2 Reporter system for detecting signal pathway activation in multiple cell types
12/08/2005WO2005116063A1 Live, oral vaccine for protection against shigella dysenteriae serotype 1
12/08/2005WO2005116061A2 Sequences for the synthesis of antibacterial polyketides